Comparison of quantum-dots- and fluorescein-isothiocyanate-based technology for detecting prostate-specific antigen expression in human prostate cancer

IET Nanobiotechnology

Volumn 5, Issue 2, 2011, Pages 47-51

  Ruan, Y ^a   Yu, W ^a   Cheng, F ^a   Zhang, X ^a   Rao, T ^a   Xia, Y ^a   Larre S ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL APPLICATIONS; DIFFERENTIAL DISPLAY; HUMAN PROSTATE CANCER; IMMUNOLABELLING; PROSTATE SPECIFIC ANTIGEN;

ANTIGENS; DISEASES; FLUORESCENCE; MEDICAL APPLICATIONS;

SEMICONDUCTOR QUANTUM DOTS;

FLUORESCEIN ISOTHIOCYANATE; PROSTATE SPECIFIC ANTIGEN; QUANTUM DOT; TUMOR MARKER;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CYTOCHEMISTRY; DRUG STABILITY; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; METABOLISM; METHODOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SENSITIVITY AND SPECIFICITY; STANDARD;

DRUG STABILITY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCYTOCHEMISTRY; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; QUANTUM DOTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 79959822645     PISSN: 17518741     EISSN: None     Source Type: Journal    
DOI: 10.1049/iet-nbt.2010.0016     Document Type: Article

References (18)

1. Xing, Y., Smith, A.M., Agrawal, A., Ruan, G., and Nie, S.: ' Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots ', Int. J. Nanomed., 2006, 1, p. 473-481 10.2147/nano.2006.1.4.473
2. Smith, A.M., Ruan, G., Rhyner, M.N., and Nie, S.: ' Engineering luminescent quantum dots for in vivo molecular and cellular imaging ', Ann. Biomed. Eng., 2006, 34, p. 3-14 10.1007/s10439-005-9000-9
3. Yu, W.W., Chang, E., Drezek, R., and Colvin, V.L.: ' Water-soluble quantum dots for biomedical applications ', Biochem. Biophys. Res. Commun., 2006, 348, p. 781-786 10.1016/j.bbrc.2006.07.160 (Pubitemid 44233496)
4. Shi, C., Zhu, Y., and Cerwinka, W.H.: et al. ' Quantum dots: emerging applications in urologic oncology ', Urol. Oncol., Semin. Orig. Invest., 2008, 26, p. 86-92 10.1016/j.urolonc.2007.03.018
5. Chen, L.D., Liu, J., and Yu, X.F.: et al. ' The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis ', Biomaterials, 2008, 29, p. 4170-4176 10.1016/j.biomaterials.2008. 07.025 0142-9612
6. Chen, C., Peng, J., and Xia, H.S.: et al. ' Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer ', Biomaterials, 2009, 30, p. 2912-2918 10.1016/j.biomaterials.2009.02.010 0142-9612
7. Resch-Genger, U., Grabolle, M., and Cavaliere-Jaricot, S.: et al. ' Quantum dots versus organic dyes as fluorescent labels ', Nat. Methods, 2008, 5, p. 763-775 10.1038/nmeth.1248
8. Gleason, D.F.: ' Histologic grading and clinical staging of prostatic carcinoma' ', Tannebaum, M., Urologic pathology: the prostate, (Lea & Febiger, Philadelphia, 1977), p. 171-197
9. Beahrs, O.H., Henson, D.E., Hutter, R.V.P., and Kennedy, B.J.: ' AJCC manual for staging of cancer ', 4th (JB Lippincott Company, Philadelphia, 1992), p. 181
10. Brocke, T., Bootsmann, M.T., and Tews, M.: et al. ' Spectroscopy of few electron collective excitations in charge-tunable artificial atoms ', Phys. Rev. Lett., 2003, 91, p. 257401-257404 10.1103/PhysRevLett.91.257401 0031-9007
11. Alivisatos, A.P., Gu, W., and Larabell, C.: ' Quantum dots as cellular probes ', Annu. Rev. Biomed. Eng., 2005, 7, p. 55-76 10.1146/annurev.bioeng.7. 060804.100432 (Pubitemid 41170185)
12. Smith, A.M., Duan, H., Mohs, A.M., and Nie, S.: ' Bioconjugated quantum dots for in vivo molecular and cellular imaging ', Adv. Drug Deliv. Rev., 2008, 60, p. 1226-1240 10.1016/j.addr.2008.03.015
13. Stege, R., Grande, M., Carlström, K., Tribukait, B., and Pousette, Å.: ' Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas ', Clin. Cancer Res., 2000, 6, p. 160-165 (Pubitemid 30064989)
14. Grande, M., Carlström, K., Rozell, B.L., Eneroth, P., Stege, R., and Pousette, Å.: ' Tissue concentrations of tissue polypeptide antigen (TPA) and prostatic specific antigen (PSA) in 42 patients with prostatic carcinoma ', Prostate, 2000, 45, p. 299-303 10.1002/1097-0045(20001201)45:4<299::AID- PROS3>3.0.CO;2-I
15. Cozzoli, P.D., Pellegrino, T., and Manan, L.: ' Synthesis, properties, and perspectives of hybrid nanocrystal structures ', Chem. Soc. Rev., 2006, 35, p. 1195-1208 10.1039/b517790c (Pubitemid 44611729)
16. Medintz, I.L., Uyeda, H.T., Goldman, E.R., and Mattoussi, H.: ' Quantum dot bioconjugates for imaging, labelling and sensing ', Nat. Mater., 2005, 4, p. 435-446 10.1038/nmat1390 (Pubitemid 40774047)
17. Cheng, F., Yu, W., Zhang, X., and Ruan, Y.: ' Quantum-dot-based technology for sensitive and stable detection of prostate stem cell antigen expression in human transitional cell carcinoma ', Int. J. Biol. Markers, 2009, 24, p. 271-276
18. Qian, X., Peng, X.H., and Ansari, D.O.: et al. ' In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags ', Nat. Biotechnol., 2007, 26, p. 83-90 10.1038/nbt1377